New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.
作者信息
Petrasko Marian, Raizada Amol, Petraskova Terezia
机构信息
Cardiovascular Disease Fellowship Program, University of South Dakota Sanford School of Medicine.
School of Arts, Washington University, St. Louis, Missouri.
出版信息
S D Med. 2016 Aug;69(8):363-369.
PMID:28806005
Abstract
摘要
相似文献
1
New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.新型口服抗凝药：处方医生应了解的内容；华法林与“新型药物”（达比加群、利伐沙班、阿哌沙班、依度沙班）之间的异同——适应证、禁忌证及使用安全性综述
S D Med. 2016 Aug;69(8):363-369.
2
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.非维生素K口服抗凝药用于非瓣膜性心房颤动的相对疗效和安全性：在三个患者亚组中比较阿哌沙班、达比加群、利伐沙班和依度沙班的网状Meta分析
Int J Cardiol. 2016 Feb 1;204:88-94. doi: 10.1016/j.ijcard.2015.11.084. Epub 2015 Nov 17.
3
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.华法林与四种非维生素K拮抗剂口服抗凝剂用于卒中二级预防时的复发卒中量及预后分析
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):338-345. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.007. Epub 2017 Oct 13.
4
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.房颤冷冻球囊消融术患者中抗凝剂相关出血和缺血并发症的比较研究
J Cardiol. 2017 Jan;69(1):11-15. doi: 10.1016/j.jjcc.2016.04.009. Epub 2016 May 7.
5
A comparison between vitamin K antagonists and new oral anticoagulants.维生素K拮抗剂与新型口服抗凝剂的比较。
Br J Clin Pharmacol. 2017 Nov;83(11):2589-2590. doi: 10.1111/bcp.13347. Epub 2017 Jul 12.
6
Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.新型口服抗凝剂对房颤患者胃肠道出血的影响：一项干预性试验的荟萃分析。
Dig Liver Dis. 2015 May;47(5):429-31. doi: 10.1016/j.dld.2015.01.159. Epub 2015 Feb 7.
7
8
Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.利伐沙班治疗非瓣膜性心房颤动的比较疗效
J Comp Eff Res. 2017 Sep;6(6):549-560. doi: 10.2217/cer-2017-0025. Epub 2017 Jul 24.
9
[Treatment of bleeding complications due to oral anticoagulant drugs].[口服抗凝药物所致出血并发症的治疗]
Laryngorhinootologie. 2015 Oct;94(10):697-709. doi: 10.1055/s-0034-1564071. Epub 2015 Oct 15.
10
Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.华法林及新型药物：口腔外科医生需要了解的内容。
Oral Maxillofac Surg Clin North Am. 2016 Nov;28(4):515-521. doi: 10.1016/j.coms.2016.06.011. Epub 2016 Sep 10.
Zotero 插件